Description

p2Ca, an 8-mer peptide, is a ligand that is naturally processed and presented to the Ld-alloreactive T cell clone, 2C. —COVID-19-immunoregulation–C47H66N8O12—-[1]Hornell TM, et al. Peptide length variants p2Ca and QL9 present distinct conformations to L(d)-specific T cells. J Immunol. 2001 Oct 15;167(8):4207-14.|[2]Connolly JM, et al. The peptide p2Ca is immunodominant in allorecognition of Ld by beta chain variable region V beta 8+ but not V beta 8- strains. Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11482-6.|[3]Tjoa BA, et al. Generation of cytotoxic T-lymphocytes to a self-peptide/class I complex: a model for peptide-mediated tumor rejection. Cancer Res. 1994 Jan 1;54(1):204-8.–142606-55-1–935.07—-O=C([C@H]1N(CCC1)C([C@H](CO)NC([C@@H](N)CC(C)C)=O)=O)N[C@@H](CC2=CC=CC=C2)C(N3[C@@H](CCC3)C(N[C@H](C(N[C@@H](CC(O)=O)C(N[C@H](C(O)=O)CC(C)C)=O)=O)CC4=CC=CC=C4)=O)=O–Inflammation/Immunology–H2O–Others—-Others–Peptides